Skip to main content

Table 1 Individuals included in the study

From: Deep histopathology genotype–phenotype analysis of focal cortical dysplasia type II differentiates between the GATOR1-altered autophagocytic subtype IIa and MTOR-altered migration deficient subtype IIb

ID

Age

Onset

Diagnosis

Gene variant/Ref.

VAF

Family history

FU

1

33

0.5

FCD IIa

DEPDC5 (SNV) [47]

Germline

None

IVA (48)

2

20

4.5

FCD IIa

DEPDC5 (SNV) [2]

Germline

None

IIA (24)

3

42

5.5

FCD IIa

DEPDC5 (CNN-LOH) [37]

Somatic (3.7%)

Father’s sister

IIB (24)

4

12

2.8

FCD IIa

DEPDC5 (SNV + LOH) [37]

Two-hit*

None

IIA (48)

5

36

9

FCD IIa

DEPDC5 (SNV) [37]

Germline

Brother son

IA (24)

6

3

0.25

FCD IIa

DEPDC5 (CNN-LOH) [37]

Somatic (4.3%)

None

IA (24)

7

1.5

0.4

FCD IIa

DEPDC5 (SNV)§

Germline

Sister

IA (24)

8

5

0.7

FCD IIa

NPRL3 (SNV) [37]

Germline

None

IA (24)

9

0.4

0

FCD IIa

NPRL3 (SNV) [37]

Germline

None

IA (16)

10

17

3.5

FCD IIa

NPRL3 (SNV) [47]

Somatic (4.5%)

None

IA (24)

11

0.5

0.1

FCD Iib/HME

MTOR (SNV) [37]

Somatic (10.5%)

None

IA (24)

12

40

17.5

FCD IIa

MTOR (SNV) [37]

Somatic (5%)

None

IA (24)

13

0.8

0.3

FCD IIa/HME

MTOR (SNV) [37]

Somatic (3.4%)

None

IA (24)

14

10

3

FCD IIb

MTOR (SNV) [37]

Somatic (5.3%)

None

IA (24)

15

19

9.5

FCD IIb

MTOR (SNV) [37]

Somatic (3.5%)

None

IA (24)

16

0.9

0.2

FCD IIb

MTOR (SNV) [37]

Somatic (3.1%)

None

IA (24)

17

0.6

0

FCD IIb/PMG

MTOR (SNV) [37]

Somatic (4.3%)

None

IA (24)

  1. Age at surgery in years; Onset: age at seizure onset; sex not shown with 50% males versus 50% females for FCD IIa and FCD IIb, respectively; Lobe: Epileptogenic focus (resulting from EEG, MRI and clinical evaluation)
  2. F frontal, T temporal, P parietal, mult multiple lobes, O occipital; Gene variant results obtained from genetic testing, SNV single nucleotide variant, CNN-LOH copy number neutral loss of heterozygosity, VAF variant allelic frequency, Ref. specific mutation described in cited reference
  3. *Germline variant at VAF = 43.1% and second hit somatic loss of heterozygosity at VAF = 3.7%
  4. $Variant not previously published and specified below; Diagnosis histopathology diagnosis, HME hemimegalencephaly, PMG polymicrogyria, FU Follow-up 2 years after surgery according to Engel`s classification: IA completely seizure free, IIA initially seizure-free, rare seizures now, IIB rare seizures since surgery, IVA no worthwhile improvement (latest available FU in month after surgery)